Capital Research Global Investors
WGS icon

Capital Research Global Investors’s GeneDx Holdings WGS Stock Holding History

Capital Research Global Investors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.7M Buy
151,055
+28,389
+23% +$2.59M ﹤0.01% 428
2025
Q4 		$16M Buy
+122,666
New +$16.8M ﹤0.01% 403

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital Research Global Investors's WGS Position: Q1 2026 in Review

Capital Research Global Investors increased its GeneDx Holdings (WGS) stake by 23% in Q1 2026, buying an estimated $2.59M and bringing the position to 151,055 shares worth $9.7M. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Capital Research Global Investors first reported a position in WGS in Q4 2025 and has held it in 2 quarters since. The position peaked at $16M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Capital Research Global Investors held 151,055 shares of GeneDx Holdings worth $9.7M as of Q1 2026.
  • Capital Research Global Investors bought 28,389 GeneDx Holdings shares in Q1 2026, an estimated $2.59M.
  • GeneDx Holdings made up ﹤0.01% of Capital Research Global Investors's portfolio in Q1 2026, its #428 holding.
  • Capital Research Global Investors first reported a position in GeneDx Holdings in Q4 2025 and has held it in 2 quarters since.
  • Capital Research Global Investors's GeneDx Holdings position peaked at $16M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.